Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

TENS + Physical Therapy Aids Fibromyalgia Symptoms

Transcutaneous electrical nerve stimulation (TENS) plus outpatient physical therapy (PT) reduces movement-based pain in patients with fibromyalgia, according to

AAD: Upadacitinib Safe, Effective for Nonsegmental Vitiligo

Treatment with upadacitinib is safe and effective for adults and adolescents with nonsegmental vitiligo (NSV), according to a study presented at the annual meet

Disputing Link, Raw Dairy Farm Recalls Raw Cheese After Outbreak

MONDAY, April 6, 2026 A California dairy farm has recalled its cheddar cheese under protest after federal health officials linked it to an E. coli outbreak that

AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy

Ixekizumab plus tirzepatide (IXE TZP) shows significant benefits for outcomes in psoriatic arthritis (PsA) versus IXE alone in adults with overweight or obesity

Annual Incidence of Treatment-Related Acute Myeloid Leukemia Is Increasing

The annual incidence of treatment-related acute myeloid leukemia (tAML) has increased, in addition to an increase in the distribution of primary cancers, define

What Sea Creatures Reveal About How Fast People Age

SUNDAY, April 5, 2026 This is no ordinary fish story.Researchers who videotaped every moment in the lives of 81 African turquoise killfish gleaned intriguing in

How to Tell if Spring Symptoms Owe to Allergy, Cold or Something More Serious

SATURDAY, April 4, 2026 When your head is splitting, your nose is running nonstop, your eyes are itching and you re coughing, coughing, coughing, what s the bes

ACC: DASH Diet Grocery Delivery Program Aids Blood Pressure, Cholesterol

Black adults with high blood pressure (BP) who receive dietitian counseling and home deliveries of groceries aligned with the Dietary Approaches to Stop Hyperte

AAD: Zasocitinib Safe, Effective for Moderate-to-Severe Plaque Psoriasis in Adults

Once-daily oral zasocitinib (TAK-279), an oral tyrosine kinase 2 (TYK2) inhibitor, provides a durable response in adults with moderate-to-severe plaque psoriasi

ACC: Percutaneous Coronary Intervention Can Be Delayed Until After TAVR in Some Patients

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) have comparable outcomes regardless of whether they unde

Popular Keywords